Coronavirus Clinical Trials

24 recruitingLast updated: May 21, 2026

There are 24 actively recruiting coronavirus clinical trials across 56 countries. Studies span Phase 3, Not Applicable, Phase 1, Phase 2. Top locations include Los Angeles, California, United States, New York, New York, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Coronavirus Trials at a Glance

24 actively recruiting trials for coronavirus are listed on ClinicalTrialsFinder across 6 cities in 56 countries. The largest study group is Phase 3 with 4 trials, with the heaviest enrollment activity in Los Angeles, New York, and Chicago. Lead sponsors running coronavirus studies include Cardresearch, Centre Hospitalier Universitaire de Nice, and BioFire Defense LLC.

Browse coronavirus trials by phase

About Coronavirus Clinical Trials

Looking for clinical trials for Coronavirus? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronavirus trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronavirus clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 24 trials

Recruiting
Phase 3

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Coronavirus Disease (COVID-19)
Merck Sharp & Dohme LLC3,082 enrolled222 locationsNCT06667700
Recruiting
Phase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

SARS-CoV-2 infectionCOVID-19Long COVID+1 more
Wes Ely550 enrolled17 locationsNCT06631287
Recruiting

COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor

Coronavirus Infections
Università Vita-Salute San Raffaele6,000 enrolled13 locationsNCT04318366
Recruiting

In-depth Immunological Investigation of COVID-19.

Coronavirus Infections
Universitaire Ziekenhuizen KU Leuven100 enrolled1 locationNCT04327570
Recruiting
Phase 1

A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

Upper respiratory tract infectionsrespiratory tract infectionCOVID-19 (SARS-CoV-2) infection+8 more
Pfizer18 enrolled1 locationNCT07552779
Recruiting

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

CoronavirusCOVID-19Coronavirus Infection
Columbia University1,000 enrolled1 locationNCT04367857
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting

Physiological Finding in Management of COVID 19 Patients

COVID-19 (Coronavirus Disease 2019)
St. Martin De Porress Hospital15,000 enrolled2 locationsNCT07504341
Recruiting

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health

Post-Coronavirus Disease 19
National Institute of Neurological Disorders and Stroke (NINDS)1,590 enrolled1 locationNCT04573062
Recruiting

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors

COVID-19 pneumoniaCOVID-19 Respiratory InfectionCOVID-19+4 more
Weill Medical College of Cornell University510 enrolled3 locationsNCT05164744
Recruiting

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

CoronavirusCOVIDRespiratory Infection
BioFire Defense LLC1,500 enrolled6 locationsNCT07221097
Recruiting

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

CoronavirusInfluenzaRespiratory Virus
National Institute of Allergy and Infectious Diseases (NIAID)1,000 enrolled1 locationNCT04772170
Recruiting
Not Applicable

Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study

CoronavirusCOVID-19Cardiac Arrest
KidSIM Simulation Program240 enrolled4 locationsNCT05868239
Recruiting

Post COVID-19 Biorepository

Coronavirus Infection
University of Kansas Medical Center100 enrolled1 locationNCT04885504
Recruiting

A Study to Explore the Role of Gut Flora in COVID-19 Infection

CoronavirusCOVID-19Gut Microbiome+5 more
ProgenaBiome250 enrolled1 locationNCT04359836
Recruiting

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

SepsisSystemic Inflammatory Response SyndromeInfection, Bacterial+3 more
Michigan State University2,500 enrolled2 locationsNCT01904188
Recruiting
Not Applicable

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

CoronavirusSARS-CoV-2 infectionCOVID-19
Centre Hospitalier Universitaire de Nīmes250 enrolled2 locationsNCT06099795
Recruiting

Capturing MultiORgan Effects of COVID-19

Multi-Organ DisorderCoronavirus Infection
University of Oxford750 enrolled1 locationNCT04510025
Recruiting
Not Applicable

Study of the Incidence of SARS-CoV-2 Infection (COVID-19)

Coronavirus Infections
Centre Hospitalier Universitaire de Nice1,000 enrolled1 locationNCT04429594
Recruiting
Phase 1Phase 2

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

Coronavirus Infection
University of Liege20 enrolled1 locationNCT04445454